Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for <i>Helicobacter pylori</i> Infection: A Systematic Review

Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for <i>Helicobacter pylori</i> Infection: A Systematic Review

Due to the increasing prevalence of antimicrobial resistance, the efficacy of standard triple therapy for <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection has declined, with eradication rates now falling below 80% in most countries. Although bismuth quadruple therapy a...

Full description

Saved in:
Bibliographic Details
Main Authors: Chih-An Shih, Deng-Chyang Wu, Chang-Bih Shie, Ping-I Hsu
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Microorganisms
Subjects:
<i>Helicobacter pylori</i>
high-dose dual therapy
triple therapy
quadruple therapy
potassium competitive acid blocker
Online Access:https://www.mdpi.com/2076-2607/13/4/715
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items